Literature DB >> 12021449

TEM-1 beta-lactamase as a scaffold for protein recognition and assay.

Daniel Legendre1, Bénédicte Vucic, Vincent Hougardy, Anne-Lise Girboux, Christophe Henrioul, Julien Van Haute, Patrice Soumillion, Jacques Fastrez.   

Abstract

A large number of different proteins or protein domains have been investigated as possible scaffolds to engineer antibody-like molecules. We have previously shown that the TEM-1 beta-lactamase can accommodate insertions of random sequences in two loops surrounding its active site without compromising its activity. From the libraries that were generated, active enzymes binding with high affinities to monoclonal antibodies raised against prostate-specific antigen, a protein unrelated to beta-lactamase, could be isolated. Antibody binding was shown to affect markedly the enzyme activity. As a consequence, these enzymes have the potential to be used as signaling molecules in direct or competitive homogeneous immunoassay. Preliminary results showed that beta-lactamase clones binding to streptavidin could also be isolated, indicating that some enzymes in the libraries have the ability to recognize proteins other than antibodies. In this paper, we show that, in addition to beta-lactamases binding to streptavidin, beta-lactamase clones binding to horse spleen ferritin and beta-galactosidase could be isolated. Affinity maturation of a clone binding to ferritin allowed obtaining beta-lactamases with affinities comprised between 10 and 20 nM (Kd) for the protein. Contrary to what was observed for beta-lactamases issued from selections on antibodies, enzyme complexation induced only a modest effect on enzyme activity, in the three cases studied. This kind of enzyme could prove useful in replacement of enzyme-conjugated antibodies in enzyme-linked immunosorbant assays (ELISA) or in other applications that use antibodies conjugated to an enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021449      PMCID: PMC2373628          DOI: 10.1110/ps.0203102

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  42 in total

1.  Phages from landscape libraries as substitute antibodies.

Authors:  V A Petrenko; G P Smith
Journal:  Protein Eng       Date:  2000-08

Review 2.  Engineered protein scaffolds for molecular recognition.

Authors:  A Skerra
Journal:  J Mol Recognit       Date:  2000 Jul-Aug       Impact factor: 2.137

3.  Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.

Authors:  B L Roberts; W Markland; A C Ley; R B Kent; D W White; S K Guterman; R C Ladner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

4.  Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling.

Authors:  E Gunneriusson; K Nord; M Uhlén; P Nygren
Journal:  Protein Eng       Date:  1999-10

5.  Beta-lactamases as fully efficient enzymes. Determination of all the rate constants in the acyl-enzyme mechanism.

Authors:  H Christensen; M T Martin; S G Waley
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  Random peptide libraries: a source of specific protein binding molecules.

Authors:  J J Devlin; L C Panganiban; P E Devlin
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

7.  Engineering regulable Escherichia coli beta-galactosidases as biosensors for anti-HIV antibody detection in human sera.

Authors:  N Ferrer-Miralles; J X Feliu; S Vandevuer; A Müller; J Cabrera-Crespo; I Ortmans; F Hoffmann; D Cazorla; U Rinas; M Prévost; A Villaverde
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

8.  Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay.

Authors:  B Friguet; A F Chaffotte; L Djavadi-Ohaniance; M E Goldberg
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

9.  Structural origins of high-affinity biotin binding to streptavidin.

Authors:  P C Weber; D H Ohlendorf; J J Wendoloski; F R Salemme
Journal:  Science       Date:  1989-01-06       Impact factor: 47.728

10.  Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity.

Authors:  E Fabbrizio; L Le Cam; J Polanowska; M Kaczorek; N Lamb; R Brent; C Sardet
Journal:  Oncogene       Date:  1999-07-29       Impact factor: 9.867

View more
  6 in total

Review 1.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

2.  Active TEM-1 beta-lactamase mutants with random peptides inserted in three contiguous surface loops.

Authors:  Pascale Mathonet; Julie Deherve; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

3.  Crystallization and preliminary X-ray diffraction analysis of kanamycin-binding β-lactamase in complex with its ligand.

Authors:  Karen Van de Water; Sameh H Soror; Alexandre Wohlkonig; Nico A J van Nuland; Alexander N Volkov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-26

Review 4.  Protein scaffold-based molecular probes for cancer molecular imaging.

Authors:  Zheng Miao; Jelena Levi; Zhen Cheng
Journal:  Amino Acids       Date:  2010-02-21       Impact factor: 3.520

5.  Spectroscopic analysis and docking simulation on the recognition and binding of TEM-1 β-lactamase with β-lactam antibiotics.

Authors:  Jianting Yang; Qian Li; Liujiao Bian
Journal:  Exp Ther Med       Date:  2017-07-31       Impact factor: 2.447

Review 6.  Miniproteins as phage display-scaffolds for clinical applications.

Authors:  Frederic Zoller; Uwe Haberkorn; Walter Mier
Journal:  Molecules       Date:  2011-03-14       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.